Ординатура / Офтальмология / Английские материалы / Modern Cataract Surgery_Kohnen_2002
.pdf
far vision, distorted far vision, depth perception, double vision (one eye), double vision (both eyes), or color distortion. There were no significant between-group differences for 8 of the visual symptoms. Subjects with the multifocal implant reported significantly more difficulty with haloes, glare/flare, and blurred far vision (p 0.014). The percentages of multifocal vs. monofocal subjects who reported ‘severe difficulty’ with these phenomena were low: 15 vs. 6% for haloes, 11 vs. 1% for glare/flare, and 4 vs. 1% for blurred far vision. These generally low values combined with high subject satisfaction scores suggest that their occasional experience of these phenomena was an acceptable tradeoff for the benefits of multifocal vision.
Javitt and Steinert [12] asked subjects in both IOL groups to rate glare disability (limitation in activities of daily living), degree of bother due to double or distorted vision, and degree of bother due to glare, haloes, or rings around lights. The rating scale was 0 (no limitation or bother) to 4 (extreme limitation or bother). No significant between-group differences were seen in glare disability or double or distorted vision. Subjects implanted with multifocal IOLs had significantly more bother with glare, haloes, or rings around lights than those implanted with monofocal IOLs (p 0.0001). In a separate study, Javitt et al. [11] found that subjects implanted with the multifocal IOL experienced more nightflare and haloes than those with the monofocal IOL. However, Lesueur et al. [18] reported similar rates of haloes and glare in the two groups: 8% with the P359 lens and 9% with the Array.
Dick et al. [8] compared multifocal and monofocal IOLs with respect to occurrence of photic phenomena (halo, flicker or forward-scattered light, glare). No differences were found between multifocal and monofocal IOLs for objective measures of these phenomena. Subjects also subjectively evaluated these symptoms by filling out a questionnaire. Nine of 28 multifocal and 3 of 27 monofocal subjects noticed light sensations (mainly haloes) that had not been present before surgery. However, the majority of subjects were not bothered by these sensations.
Stereoacuity and aniseikonia following unilateral or bilateral implantation of the Array lens was evaluated by Häring et al. [26]. The unilateral and bilateral groups had similar stereoacuity, but distance and near aniseikonia were significantly less in the bilateral than the unilateral group. However, the authors concluded that the Array multifocal IOL allowed good binocular vision despite the simultaneous formation of multiple retinal images. Arens et al. [6] tested best visual acuity in three bright light conditions (comparable to: bright overhead commercial lighting, partly cloudy day, direct overhead sunlight) in 21 patients with bilateral Array multifocal IOLs and 15 patients with bilateral monofocal IOLs. For binocular vision, multifocal subjects had slightly better visual acuity in all three light conditions than the monofocal patients, but the differences were
Claoué/Parmar |
232 |
not statistically significant. For monocular vision, there were almost no differences between the multifocal and monofocal eyes. Therefore, no disadvantages were found for multifocal IOLs at any glare level tested with this method.
Vaquero-Ruano et al. [7] found that the occurrence of ghost images and glare was similar in the Array multifocal (n 50) and monofocal IOL subjects (n 50). At 18 months after surgery, ghost images were reported by 6% of multifocal and by 2% of monofocal subjects; glare reported by 4 and 2%, respectively. However, all subjects found these visual symptoms were tolerable and none wished to have the IOL removed.
In summary, certain visual symptoms such as glare, haloes, blurred vision, or ghosting may occur occasionally in subjects implanted with multifocal IOLs. These symptoms, however, appear to mild enough so as not to detract from overall subject satisfaction. Many subjects with monofocal IOLs implanted also note haloes and glare. Much of the skill in using multifocal IOLs is ensuring that subjects are reassured that ‘haloes’ are a ‘symptom’ that the IOL is ‘working properly’! If presented to the subject in this fashion, there is usually an immediate reduction of subject anxiety and a rapid adaptation to pseudo-accommodation.
Driving Ability
The effect of multifocal IOLs on driving ability at night and in other low contrast situations has been studied because of concern over the reduced visual acuity at low contrast levels and occurrence of glare symptoms reported in multifocal subjects.
Featherstone et al. [9] conducted a novel driving study using the Iowa Driving Simulator in subjects with bilateral Array multifocal IOLs (n 33) or bilateral monofocal IOLs (n 33). Under three poor visibility conditions (clear weather at night with or without a glare source, fog), 30 different measures of driving performance were made. In 26 of the 30 (87%) comparisons, the Array multifocal and monofocal subjects had similar performances. In the 4 comparisons in which the Array multifocal group was lower than the monofocal group, the subjects with multifocal IOLs still performed, on average, within safety guidelines. The authors concluded that there were no consistent differences in driving performance and safety, but that multifocal subjects may have more difficulty in recognizing certain traffic signs while driving during the night or poor visibility conditions.
Grosskopf et al. [10] prospectively assessed visual acuity under various contrast and glare levels in order to determine nighttime driving ability in subjects with beginning cataracts (n 41), Array multifocal IOLs (n 50), and monofocal IOLs (n 85). According to the criteria of the German Ophthalmological Society, which are generally considered to be rather strict, only 38% of the multifocal subjects and 41% of the monofocal subjects met the standards
Multifocal Intraocular Lenses |
233 |
|
100 |
|
|
|
80 |
|
|
subjects |
60 |
|
|
|
|
Mono/Multi |
|
of |
|
|
Bilat Multi |
Percent |
|
|
|
40 |
|
Unilat Multi |
|
|
|
|
|
|
20 |
|
|
|
0 |
|
|
|
Near |
Intermediate |
Distance |
|
|
|
|
Fig. 4. Subjects able to function without spectacles (from Steinert et al. [3]).
for nighttime driving ability. The authors concluded that elderly pseudophakic subjects and those with beginning cataracts should be informed that their nighttime driving ability may be impaired, even if their visual acuity is sufficient.
Independence from Spectacles
In the Array safety and efficacy study by Steinert et al. [3] the percent of subjects with bilateral multifocal IOLs who could function comfortably without spectacles were 93% for distance, 93% for intermediate, and 81% for near vision (fig. 4). These percentages were generally greater for subjects who had received bilateral Arrays. For near vision, a significantly higher percentage of subjects with bilateral multifocal IOLs could function comfortably without eyeglasses (81% (96 of 118)), compared to 56% (93 of 165; p 0.001) of multifocal/monofocal subjects, or to 58% (56 of 97; p 0.001) with unilateral monofocals. Thus, the full advantages of multifocality are more likely gained with bilateral implantation. If a subject requires cataract surgery and aspires to be spectacle-independent, then only implantation of multifocal IOLs can achieve this with preservation of stereopsis.
Patient Satisfaction and Quality of Life
Patient satisfaction at 1 year postsurgery in the study by Steinert et al. [3] was very high. More than 90% of subjects were moderately or very satisfied, and more than 90% of them would choose the same IOL again.
Claoué/Parmar |
234 |
Subjects in the multifocal IOL groups in the studies by Javitt and Steinert [12] and Javitt et al. [11] rated their vision without glasses better overall, at near, and at intermediate distances than subjects in the monofocal IOL groups (p 0.05). Subjects with the Array demonstrated better visual function for near tasks and social activities and less spectacle dependency that subjects implanted with traditional monofocal IOLs.
All 50 subjects with implanted Array IOLs in the study by Vaquero-Ruano et al. [7] were satisfied with the lens and their increased range of functional vision, even if they were not fully independent of spectacles. Brydon et al. [27] also found that subjects with bilateral Array IOLs were significantly more pleased with their improved vision than subjects with bilateral monofocals, based upon mean scores on the VF-14 index of visual function (p 0.003).
In subjects with unilateral implantation of the CeeOn 811E diffractive bifocal [19], 31% (11 of 35) were dissatisfied with their uncorrected distance and near vision; the authors suggest that this high dissatisfaction rate is related to the unilateral implantation. Of the other subjects, 43% (15 of 35) were satisfied and 26% (9 of 35) were highly satisfied. After best distance correction, 57% (20 of 35) were satisfied, 37% (13 of 35) were highly satisfied, and only 6% (2 of 35) were dissatisfied. Eighty-nine percent (31/35) of subjects said they would choose the same IOL for their fellow eye.
Conclusion
Multifocal IOLs more closely replicate the near to far vision of the prepresbyopic crystalline lens than monofocal IOLs and may well offer definite advantages over monofocal IOLs. Refractive multifocal IOLs, refractive bifocal IOLs and diffractive bifocal IOLs all showed distance vision comparable to monofocal IOLs. The Array refractive multifocal IOL provided significantly better near visual acuity and significantly greater depth of focus than monofocal IOLs. The Domilens Progress 1 refractive multifocal IOL provided intermediate and near visual acuity comparable to monofocal IOLs. The True Vista refractive bifocal IOL provided better uncorrected near vision and distance-corrected near vision than monofocal IOLs. The diffractive bifocal IOLs – CeeOn 811E, Pharmacia 808X, 3M 825X and 3M 815LE – provided good distance and near visual acuities. The diffractive optics, however, do not use all available light and this appears to have a negative impact on low contrast sensitivity.
As for the future, we would hope for an injectable accommodative implant which would virtually mimic the physiological behavior of the lens – although this is clearly a distant wish at present.
Multifocal Intraocular Lenses |
235 |
References
1Ravalico G, Baccara F, Bellavitis A: Refractive bifocal intraocular lens and pupillary diameter. J Cataract Refract Surg 1992;18:594–597.
2Steinert R: Visual outcomes with multifocal intraocular lenses. Curr Opin Ophthalmol 2000;11: 12–21.
3Steinert RF, Aker BL, Trentacost DJ, Smith PJ, Tarantino N: A prospective comparative study of the AMO Array zonal-progressive multifocal silicone intraocular lens and a monofocal intraocular lens. Ophthalmology 1999;106:1243–1255.
4Ravalico G, Parentin F, Sirotti P, Baccara F: Analysis of light energy distribution by multifocal intraocular lenses through an experimental optical model. J Cataract Refract Surg 1998;24: 647–652.
5Knorz MC, Claessens D, Schaefer RC, Sieberth V, Liesenhoff H: Evaluation of contrast acuity and defocus curve in bifocal and monofocal intraocular lenses. J Cataract Refract Surg 1993;19: 513–523.
6Arens B, Freudenthaler N, Quentin CD: Binocular function after bilateral implantation of monofocal and refractive multifocal intraocular lenses. J Cataract Refract Surg 1999;25:399– 404.
7Vaquero-Ruano M, Encinas JL, Millan I, Hijos M, Cajigal C: AMO Array multifocal versus monofocal intraocular lenses: Long-term follow-up. J Cataract Refract Surg 1998;24:118–123.
8Dick H, Krummenauer F, Schwenn O, Krist R, Pfeiffer N: Objective and subjective evaluation of photic phenomena after monofocal and multifocal intraocular lens implantation. Ophthalmology 1999;106:1878–1886.
9Featherstone KA, Bloomfield JR, Lang AJ, Miller-Meeks MJ, Woodworth G, Steinert RF: Driving simulation study: Bilateral Array multifocal versus bilateral AMO monofocal intraocular lenses. J Cataract Refract Surg 1999;25:1254–1262.
10Grosskopf U, Wagner R, Jacobi F, Krzizok T: Contrast sensitivity and glare sensitivity in patients with monofocal or multifocal pseudophakic eyes (in German). Ophthalmologe 1998;95:432–437.
11Javitt J, Brauweiler HP, Jacobi KW, Klemen U, Kohnen S, Quentin CD, Teping C, Pham T, Knorz MC, Poetzsch D: Cataract extraction with multifocal IOL implantation: A multicenter clinical trial in Germany and Austria evaluating clinical, functional and quality-of-life outcomes. J Cataract Refract Surg 2000;26:1356–1366.
12Javitt JC, Steinert RF: Cataract extraction with multifocal IOL implantation: A multinational clinical trial evaluating clinical, functional and quality-of-life outcomes. Ophthalmology 2000; 107:2040–2048.
13Ravalico G, Parentin F, Pastori G, Baccara F: Spatial resolution threshold in pseudophakic patients with monofocal and multifocal intraocular lenses. J Cataract Refract Surg 1998;24:244–248.
14Liekfeld A, Walkow T, Anders N, Pham DT, Wollensak J: Prospective comparison of two multifocal lens models (in German). Ophthalmologe 1998;95:253–256.
15Pieh S, Weghaupt H, Skorpik C: Contrast sensitivity and glare disability with diffractive and refractive multifocal intraocular lenses. J Cataract Refract Surg 1998;24:659–662.
16Weghaupt H, Pieh S, Skorpik C: Multifocal intraocular lenses as an alternative in cataract surgery (in German). Wien Med Wochenschr 1997;147:298–301.
17Weghaupt H, Pieh S, Skorpik C: Comparison of pseudoaccommodation and visual quality between a diffractive and refractive multifocal intraocular lens. J Cataract Refract Surg 1998;24: 663–665.
18Lesueur L, Gajan B, Nardin M, Chapotot E, Arne JL: Comparison of visual results and quality of vision between two multifocal intraocular lenses. Multifocal silicone and bifocal PMMA. J Fr Ophtalmol (in French) 2000;23:355–359.
19Avitabile T, Marano F, Canino E, Biondi S, Reibaldi A: Long-term visual results of bifocal intra-ocular lens implantation. J Cataract Refract Surg 1999;25:1263–1269.
20Knorz MC: Results of a European multicenter study of the True Vista bifocal intraocular lens. J Cataract Refract Surg 1993;19:626–634.
21Knorz MC, Koch DD, Martinez-Franco C, Lorger CV: Effect of pupil size and astigmatism on contrast acuity with monofocal and bifocal intraocular lenses. J Cataract Refract Surg 1994;20: 26–33.
Claoué/Parmar |
236 |
22Knorz MC, Seiberth V, Ruf M, Lorger CV, Liesenhoff H: Contrast sensitivity with monofocal and bifocal intraocular lenses. Ophthalmologica 1996;210:155–159.
23Allen ED, Burton RL, Webber SK, Haaskjold E, Sandvig K, Jyrkkio H, Leite E, Nystrom A, Wollensak J: Comparison of a diffractive bifocal and a monofocal intraocular lens. J Cataract Refract Surg 1996;22:446–451.
24Haaskjold E, Allen E, Burton R, Webber SK, Sandvig KU, Jyrkkio H, Leite E, Liekfeld A, Philipson B, Nystrom A, Wollensak J: Contrast sensitivity after implantation of diffractive bifocal and monofocal intraocular lenses. J Cataract Refract Surg 1998;24:653–658.
25Kamath GG, Prasad S, Danson A, Phillips RP: Visual outcome with the Array multifocal intraocular lens in patients with concurrent eye disease. J Cataract Refract Surg 2000;26:576–581.
26Häring G, Gronemeyer A, Hedderich J, de Decker W: Stereoacuity and aniseikonia after unilateral and bilateral implantation of the Array refractive multifocal intraocular lens. J Cataract Refract Surg 1999;25:1151–1156.
27Brydon KW, Tokarewicz AC, Nichols BD: AMO Array multifocal lens versus monofocal correction in cataract surgery. J Cataract Refract Surg 2000;26:96–100.
28Yang HC, Chung SK, Baek NH: Decentration, tilt, and near vision of the Array multifocal intraocular lens. J Cataract Refract Surg 2000;26:586–589.
29Jacobi FK, Kammann J, Jacobi KW, Grosskopf U, Walden K: Bilateral implantation of asymmetrical diffractive multifocal intraocular lenses. Arch Ophthalmol 1999;117:17–23.
30Weghaupt H, Pieh S, Skorpik C: Visual properties of the foldable Array multifocal intraocular lens. J Cataract Refract Surg 1996;22(suppl 2):1313–1317.
31Ravalico G, Baccara F, Isola V: Functional evaluation of a new type of intraocular lens: Domilens type Progress 1 (in French). J Fr Ophtalmol 1994;17:175–181.
Charles Claoué, MD, DBCG, PO Box 12650, London SE3 9ZZ (UK)
Tel. 44 020 8852 8522, Fax 44 020 8852 8522, E-Mail eyes@dbcg.co.uk
Multifocal Intraocular Lenses |
237 |
Author Index
Alió, J.L. 59, 97, 106 |
Findl, O. |
131 |
|
Masket, S. 85 |
|
Anterist, N. 25 |
Fine, I.H. |
32 |
|
Menapace, R. 131 |
|
Arshinoff, S.A. 13 |
Friedman, N.J. 74 |
Mester, U. 25 |
|||
Attia, W.H. 59 |
|
|
|
Muñoz, G. 106 |
|
Auffarth, G.U. 141, 202 |
Gills, J.P. |
209 |
|
|
|
|
|
|
|
|
Olson, R.J. 79 |
Baumeister, M. 187 |
Haigis, W. 119 |
|
|
||
Becker, K.A. 202 |
Hauck, C. 25 |
|
Packer, M. 32 |
||
Bellucci, R. 1 |
Hitzenberger, C.K. 131 |
Parmar, D. 217 |
|||
Bühren, J. 187 |
Hoffman, R.S. 32 |
|
|||
|
|
|
|
|
Ries, M. 202 |
Claoué, C. 217 |
Jaullery, S. 195 |
|
Ruiz-Moreno, J.M. 97 |
||
Davis, E.A. 44 |
Kammann, J. 41 |
Shalaby, A.M.M. 59 |
|||
Dornbach, G. 41 |
Kiss, B. 131 |
|
Sourdille, P. 195 |
||
Drexler, W. 131 |
Koch, D.D. 74 |
|
|
||
|
|
Kohnen, T. 74, 155, 187 |
Tetz, M.R. 202 |
||
Fabian, E. |
147 |
|
|
|
|
Faller, U. |
202 |
Limberger, I.-J. |
202 |
Völcker, H.E. 202 |
|
Fenzl, R.E. 209 |
Lindstrom, R.L. |
44 |
|
||
Fercher, A.F. 131 |
Löw, M. 25 |
|
Wang, L. 141 |
||
238
Subject Index
Anesthesia, see Topical anesthesia, cataract surgery
Anterior chamber depth capsule shrinkage effects 139 IOLMaster measurement 123
Scheimpflug imaging 189, 190 Anterior chamber phacoemulsification
comparison with phaco stop and chop best-corrected visual acuity 62, 71 corneal edema 62, 71
corneal thickness 68, 71 endothelial cell count 66, 67, 71 evaluation parameters (table) 64, 65 intraocular pressure 62, 63
laser flare cell meter count 65, 71 ultrasound time, power 62
historical perspective 59, 60, 68 indications 72
patient selection, evaluation 60 phacoemulsification techniques,
popularity 68–70 postoperative treatment, follow-up
61, 62 technique 60, 61
Aspiration, phacoemulsification 80
Biometry, see Optical coherence biometry, Scheimpflug imaging, Ultrasound biometry
Brunescent cataract, see Nuclear mature cataract
Capsular tension ring actions 106, 113, 114, 117
anterior capsule contraction syndrome 115, 116
case studies 106–109, 111 indications 106, 112, 113 material 106, 111
posterior capsule opacification 116, 117, 195
scleral fixation 114, 115 sizes 111, 112 suppliers 111
zonular dialysis, signs of loose or broken zonules 115
Capsulorhexis, see also Cortical mature cataract, Tilt and tumble phacoemulsification
ophthalmic viscosurgical devices 20–22 visibility enhancement techniques 88
Cocaine, topical anesthesia, cataract surgery 1
Cortical mature cataract anterior capsulorhexis 87–89 clinical features 85–87
complication management, surgery 92 cortex removal 92
hydrodissection 89, 90 morgagnian cataract 87 nuclear emulsification 92 preoperative evaluation 87
viscoelastic agent selection 88, 89 visualization, anterior capsule 89
Dispersive-cohesive viscoelastic soft shell technique, ophthalmic viscosurgical device utilization 14, 16
239
EasyPack, foldable intraocular lens injection 150, 152, 153
EasySert, foldable intraocular lens injection 150–152
Extracapsular cataract extraction, phacoemulsification comparison 59, 70, 71
Foldable lens, see Intraocular lens
Fuchs’ dystrophy, ultrasound-assisted phaco aspiration case studies 81, 82
Healon, see Ophthalmic viscosurgical device, Viscoelastics
Indocyanine green, anterior capsule visualization, mature cataract surgery 89
Intralenticular opacification, incidence with piggyback lens implantation 213–215
Intraocular lens
biometry, see Optical coherence biometry, Scheimpflug imaging, Ultrasound biometry
capsule shrinkage effects, anterior chamber depth 139
historical perspective 217 incisions, foldable lens implantation
cadaver eyes, globe preparation for study 156
caliper development, incision size measurement
design 166, 167 performance 175, 177 standard calipers 158
clinical studies
factors affecting incision size 180–184
lens features 162, 163 measurement, incision size 165,
173–175, 180 patients 162, 163 statistical analysis 165
surgical procedure 164, 165 corneal damage, insertion through
minimal incision 161, 162, 169, 170, 173, 178–180
incision size determination 159–161 intact globe versus removed cornea
measurement 167–170
lens and implantation device type effects, incision size 157, 158, 168, 175, 177, 178, 180–184
minimum incision size studies 169, 170, 177, 178
rationale, foldable lenses and small incision size 155, 190
scanning electron microscopy, incisions 161, 162, 170, 173, 178, 179
surgical procedure 158, 159 injector systems, foldable lens
implantation
classification, inserter systems 147 EasyPack 150, 152, 153
EasySert 150–152 historical perspective 152
injection technique 147, 149, 153, 154
Lens Injector Set 150–152 lens specificity 152, 153 Microserter 149–151 Monarch 149, 151
Mport 149, 150, 152, 153 Passport 149, 150, 153 Sensar 149
Unfolder 149, 151
lens-capsule distance measurement 137, 138
multifocal intraocular lens, see Multifocal intraocular lens
ophthalmic viscosurgical devices, implantation 20
piggyback intraocular lens implantation high-hyperopia treatment
measurements and calculations 209–211
surgical technique 211, 212 indications 209
intralenticular opacification incidence 213–215
secondary implantation, overor underpowered pseudophakes 212, 213
Subject Index |
240 |
posterior capsule opacification,
see Posterior capsule opacification posterior chamber intraocular lens
implantation, vitreous cavity phacoemulsification 102
Scheimpflug imaging, foldable lenses anterior chamber depth 189, 190 decentration 189–191
lenses, evaluation 187, 189, 191 posterior capsule opacification 189,
192 technique 189 tilt 189–191
white-to-white measurement, see Orbscan topography system
Intumescent cataract, see Cortical mature cataract
IOLMaster
anterior chamber depth measurement 123
instrumentation 119, 120 intraocular lens constant optimization
125–127 keratometry 123
observer dependence and learning curve 124
refractive outcome after cataract surgery compared with ultrasound biometry 135, 136
ultrasound axial length comparison and conversion 120–123
Laser
interference biometry, see Optical coherence biometry
phacoemulsification safety 79
Lens Injector Set, foldable intraocular lens injection 150–152
Lidocaine, topical anesthesia for cataract surgery
formulations 3, 4 gel 7
intraocular penetration 4, 5 side effects 5
sponges 8 systemic levels 4, 5 toxicity 5
Mature cataract, see Cortical mature cataract, Nuclear mature cataract Microserter, foldable intraocular lens
injection 149–151
Monarch, foldable intraocular lens injection 149, 151
Morgagnian cataract, see Cortical mature cataract
Mport, foldable intraocular lens injection 149, 150, 152, 153
Multifocal intraocular lens
advantages over monofocal lenses 235 designs
models and manufacturers 218, 219, 235
refractive versus diffractive optics 218 effectiveness of models
combined distance and near visual acuities 228
contrast sensitivity 230, 231 depth of focus 228–230
distance visual acuity 221, 224, 225 driving ability 233, 234 independence from spectacles 234 measures 221
near visual acuity 226–228
patient satisfaction and quality of life 234, 235
table 222, 223
visual symptoms 231–233 rationale for development 217, 218
Nuclear mature cataract clinical features 85, 93 definition 93
surgical management advantages 95 capsulorhexis 94 hydrodissection 94 nuclear emulsification 94 nuclear sculpting 94, 95 preoperative evaluation 93
Ophthalmic viscosurgical device, see also Viscoelastics
advantages and limitations of classes 14, 16
Subject Index |
241 |
